Identification of cancer hallmarks associated with benefit in advanced gastroesophageal adenocarcinoma patients treated with checkpoint blockade.

Emon Elboudwarej,Carrie Baker Brachmann,Daniel V.T. Catenacci,David Cunningham,Eric Van Cutsem,Richard D. Kennedy,Shauna Lambe,Gemma E Logan,Jean-Philippe Metges,Kei Muro,Taroh Satoh,Atsuo Takashima,Zev A. Wainberg,Steven M. Walker,Kensei Yamaguchi,Marianna Zavodovskaya,Scott D. Patterson,Pankaj Bhargava,Narikazu Boku,Manish A. Shah,Adx

Identification of cancer hallmarks associated with benefit in advanced gastroesophageal adenocarcinoma patients treated with checkpoint blockade.

2020

439Background: The benefit of checkpoint blockade in advanced gastric cancer is limited and biomarkers related to response are needed. Novel gene expression analysis software was used to identify H...

Keywords:

Cancer
Adenocarcinoma
Internal medicine
Blockade
Oncology
Medicine
Pathology
Biomarker (medicine)
novel gene
expression analysis
gastroesophageal adenocarcinoma
advanced gastric cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations